Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2014

01-09-2014 | Basic Science

MiR-9 regulates the post-transcriptional level of VEGF165a by targeting SRPK-1 in ARPE-19 cells

Authors: Changshin Yoon, Daejin Kim, Seonghan Kim, Ga Bin Park, Dae Young Hur, Jae Wook Yang, Sae Gwang Park, Yeong Seok Kim

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 9/2014

Login to get access

Abstract

Purpose

To investigate the effect of the overexpression of miRNA-9 to the ratio of pro- and anti-angiogenic isoforms of vascular endothelial growth factor (VEGF) in human retinal pigment cells (ARPE-19).

Methods

Oxidative stress was induced to ARPE-19 cells by 4-hydroxynonenal (4-HNE), tert-butyl hydroperoxide (t-BH), and hypoxia chamber with 1 % O2. Expression patterns of miRNAs were validated by qPCR. Relative mRNA levels of VEGF and PEDF were measured by semi-quantitative PCR. After the transfection of miR-9 mimic and inhibitor, transcriptional levels of VEGF165a, VEGF 165b, and SRPK-1 were measured by qPCR.

Results

We demonstrated that miR-9 expression is decreased in ARPE-19 human retinal pigment cells under hypoxic stress induced by 4-HNE, a lipid peroxidation end-product. We observed that miR-9 mimic transfection of ARPE-19 inhibited one of its targets, serine-arginine protein kinase-1 (SRPK-1), modulating the transcriptional level of VEGF165b. Transfection of miR-9 reduced the alternative splicing of VEGF165a mRNA in ARPE-19 cells under hypoxic conditions, suggesting that miR-mediated regulation of alternative splicing could be a potential therapeutic target in neovascular pathologies.

Conclusions

Hypoxic stress decreased the miR-9 level in ARPE-19 cells, which increased the transcriptional level of SRPK-1, resulting in alternative splicing shift to pro-angiogenic isoforms of VEGF165 in human retinal pigment epithelial cells
Literature
2.
go back to reference Fine SL, Berger JW, Maguire MG, Ho AC (2000) Age-related macular degeneration. N Engl J Med 342:483–492PubMedCrossRef Fine SL, Berger JW, Maguire MG, Ho AC (2000) Age-related macular degeneration. N Engl J Med 342:483–492PubMedCrossRef
4.
go back to reference Bowes Rickman C, Farsiu S, Toth CA, Klingeborn M (2013) Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging. Invest Ophthalmol Vis Sci 54: ORSF68-80 Bowes Rickman C, Farsiu S, Toth CA, Klingeborn M (2013) Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging. Invest Ophthalmol Vis Sci 54: ORSF68-80
5.
go back to reference Buschini E, Piras A, Nuzzi R, Vercelli A (2011) Age-related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol 95:14–25PubMedCrossRef Buschini E, Piras A, Nuzzi R, Vercelli A (2011) Age-related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol 95:14–25PubMedCrossRef
6.
go back to reference Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, Mobley JA, Curcio CA (2010) Abundant lipid and protein components of drusen. PLoS One 5: e10329 Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, Mobley JA, Curcio CA (2010) Abundant lipid and protein components of drusen. PLoS One 5: e10329
7.
go back to reference Rabin DM, Rabin RL, Blenkinsop TA, Temple S, Stern JH (2013) Chronic oxidative stress upregulates Drusen-related protein expression in adult human RPE stem cell-derived RPE cells: a novel culture model for dry AMD. Aging 5:51–66PubMedCentralPubMed Rabin DM, Rabin RL, Blenkinsop TA, Temple S, Stern JH (2013) Chronic oxidative stress upregulates Drusen-related protein expression in adult human RPE stem cell-derived RPE cells: a novel culture model for dry AMD. Aging 5:51–66PubMedCentralPubMed
8.
go back to reference Ardeljan D, Chan CC (2013) Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res 37:68–89PubMedCrossRef Ardeljan D, Chan CC (2013) Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res 37:68–89PubMedCrossRef
9.
go back to reference Salminen A, Kauppinen A, Hyttinen JM, Toropainen E, Kaarniranta K (2010) Endoplasmic reticulum stress in age-related macular degeneration: trigger for neovascularization. Mol Med 16:535–542PubMedCentralPubMedCrossRef Salminen A, Kauppinen A, Hyttinen JM, Toropainen E, Kaarniranta K (2010) Endoplasmic reticulum stress in age-related macular degeneration: trigger for neovascularization. Mol Med 16:535–542PubMedCentralPubMedCrossRef
10.
go back to reference Tuo J, Grob S, Zhang K, Chan CC (2012) Genetics of immunological and inflammatory components in age-related macular degeneration. Ocul Immunol Inflamm 20:27–36PubMedCentralPubMedCrossRef Tuo J, Grob S, Zhang K, Chan CC (2012) Genetics of immunological and inflammatory components in age-related macular degeneration. Ocul Immunol Inflamm 20:27–36PubMedCentralPubMedCrossRef
11.
go back to reference Zarbin MA (2004) Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122:598–614PubMedCrossRef Zarbin MA (2004) Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122:598–614PubMedCrossRef
12.
go back to reference Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81–128PubMedCrossRef Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81–128PubMedCrossRef
13.
go back to reference Poli G, Schaur RJ (2000) 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50:315–321PubMedCrossRef Poli G, Schaur RJ (2000) 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50:315–321PubMedCrossRef
14.
go back to reference Shimokawa I, Higami Y, Horiuchi S, Iwasaki M, Ikeda T (1998) Advanced glycosylation end products in adrenal lipofuscin. J Gerontol A Biol Sci Med Sci 53:B49–51PubMedCrossRef Shimokawa I, Higami Y, Horiuchi S, Iwasaki M, Ikeda T (1998) Advanced glycosylation end products in adrenal lipofuscin. J Gerontol A Biol Sci Med Sci 53:B49–51PubMedCrossRef
15.
go back to reference Kim HC, Bing G, Jhoo WK, Kim WK, Shin EJ, Park ES, Choi YS, Lee DW, Shin CY, Ryu JR, Ko KH (2002) Oxidative damage causes formation of lipofuscin-like substances in the hippocampus of the senescence-accelerated mouse after kainate treatment. Behav Brain Res 131:211–220PubMedCrossRef Kim HC, Bing G, Jhoo WK, Kim WK, Shin EJ, Park ES, Choi YS, Lee DW, Shin CY, Ryu JR, Ko KH (2002) Oxidative damage causes formation of lipofuscin-like substances in the hippocampus of the senescence-accelerated mouse after kainate treatment. Behav Brain Res 131:211–220PubMedCrossRef
16.
go back to reference Carbone DL, Doorn JA, Kiebler Z, Petersen DR (2005) Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase. Chem Res Toxicol 18:1324–1331PubMedCrossRef Carbone DL, Doorn JA, Kiebler Z, Petersen DR (2005) Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase. Chem Res Toxicol 18:1324–1331PubMedCrossRef
17.
go back to reference Svendsen MN, Werther K, Nielsen HJ, Kristjansen PE (2002) VEGF and tumour angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusion. Scand J Gastroenterol 37:373–379PubMedCrossRef Svendsen MN, Werther K, Nielsen HJ, Kristjansen PE (2002) VEGF and tumour angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusion. Scand J Gastroenterol 37:373–379PubMedCrossRef
18.
go back to reference Lichtenberger BM, Tan PK, Niederleithner H, Ferrara N, Petzelbauer P, Sibilia M (2010) Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell 140:268–279PubMedCrossRef Lichtenberger BM, Tan PK, Niederleithner H, Ferrara N, Petzelbauer P, Sibilia M (2010) Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell 140:268–279PubMedCrossRef
19.
go back to reference Kwak N, Okamoto N, Wood JM, Campochiaro PA (2000) VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 41:3158–3164PubMed Kwak N, Okamoto N, Wood JM, Campochiaro PA (2000) VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 41:3158–3164PubMed
20.
go back to reference Gordon MS, Mendelson DS, Kato G (2010) Tumor angiogenesis and novel antiangiogenic strategies. Int J Cancer 126:1777–1787PubMed Gordon MS, Mendelson DS, Kato G (2010) Tumor angiogenesis and novel antiangiogenic strategies. Int J Cancer 126:1777–1787PubMed
21.
go back to reference Koolwijk P, Peters E, van der Vecht B, Hornig C, Weich HA, Alitalo K, Hicklin DJ, Wu Y, Witte L, van Hinsbergh VW (2001) Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C-induced tube formation by human microvascular endothelial cells in fibrin matrices in vitro. Angiogenesis 4:53–60PubMedCrossRef Koolwijk P, Peters E, van der Vecht B, Hornig C, Weich HA, Alitalo K, Hicklin DJ, Wu Y, Witte L, van Hinsbergh VW (2001) Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C-induced tube formation by human microvascular endothelial cells in fibrin matrices in vitro. Angiogenesis 4:53–60PubMedCrossRef
22.
go back to reference Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX (2006) Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. Faseb J 20:323–325PubMed Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX (2006) Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. Faseb J 20:323–325PubMed
23.
go back to reference Tombran-Tink J, Pawar H, Swaroop A, Rodriguez I, Chader GJ (1994) Localization of the gene for pigment epithelium-derived factor (PEDF) to chromosome 17p13.1 and expression in cultured human retinoblastoma cells. Genomics 19:266–272PubMedCrossRef Tombran-Tink J, Pawar H, Swaroop A, Rodriguez I, Chader GJ (1994) Localization of the gene for pigment epithelium-derived factor (PEDF) to chromosome 17p13.1 and expression in cultured human retinoblastoma cells. Genomics 19:266–272PubMedCrossRef
24.
go back to reference Cai J, Jiang WG, Grant MB, Boulton M (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281:3604–3613PubMedCrossRef Cai J, Jiang WG, Grant MB, Boulton M (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281:3604–3613PubMedCrossRef
25.
go back to reference Nozaki M, Sakurai E, Raisler BJ, Baffi JZ, Witta J, Ogura Y, Brekken RA, Sage EH, Ambati BK, Ambati J (2006) Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J Clin Invest 116:422–429PubMedCentralPubMedCrossRef Nozaki M, Sakurai E, Raisler BJ, Baffi JZ, Witta J, Ogura Y, Brekken RA, Sage EH, Ambati BK, Ambati J (2006) Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J Clin Invest 116:422–429PubMedCentralPubMedCrossRef
26.
go back to reference Gao G, Li Y, Zhang D, Gee S, Crosson C, Ma J (2001) Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett 489:270–276PubMedCrossRef Gao G, Li Y, Zhang D, Gee S, Crosson C, Ma J (2001) Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett 489:270–276PubMedCrossRef
27.
go back to reference Lee JH, Canny MD, De Erkenez A, Krilleke D, Ng YS, Shima DT, Pardi A, Jucker F (2005) A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc Natl Acad Sci U S A 102:18902–18907PubMedCentralPubMedCrossRef Lee JH, Canny MD, De Erkenez A, Krilleke D, Ng YS, Shima DT, Pardi A, Jucker F (2005) A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc Natl Acad Sci U S A 102:18902–18907PubMedCentralPubMedCrossRef
28.
go back to reference Nowak DG, Amin EM, Rennel ES, Hoareau-Aveilla C, Gammons M, Damodoran G, Hagiwara M, Harper SJ, Woolard J, Ladomery MR, Bates DO (2010) Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. J Biol Chem 285:5532–5540PubMedCentralPubMedCrossRef Nowak DG, Amin EM, Rennel ES, Hoareau-Aveilla C, Gammons M, Damodoran G, Hagiwara M, Harper SJ, Woolard J, Ladomery MR, Bates DO (2010) Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. J Biol Chem 285:5532–5540PubMedCentralPubMedCrossRef
29.
go back to reference Biselli-Chicote PM, Oliveira AR, Pavarino EC, Goloni-Bertollo EM (2012) VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer. J Cancer Res Clin Oncol 138:363–370PubMedCrossRef Biselli-Chicote PM, Oliveira AR, Pavarino EC, Goloni-Bertollo EM (2012) VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer. J Cancer Res Clin Oncol 138:363–370PubMedCrossRef
30.
go back to reference Konopatskaya O, Churchill AJ, Harper SJ, Bates DO, Gardiner TA (2006) VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis 12:626–632PubMed Konopatskaya O, Churchill AJ, Harper SJ, Bates DO, Gardiner TA (2006) VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis 12:626–632PubMed
32.
go back to reference Selcuklu SD, Donoghue MT, Rehmet K, de Souza GM, Fort A, Kovvuru P, Muniyappa MK, Kerin MJ, Enright AJ, Spillane C (2012) MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem 287:29516–29528PubMedCentralPubMedCrossRef Selcuklu SD, Donoghue MT, Rehmet K, de Souza GM, Fort A, Kovvuru P, Muniyappa MK, Kerin MJ, Enright AJ, Spillane C (2012) MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem 287:29516–29528PubMedCentralPubMedCrossRef
34.
35.
go back to reference Coolen M, Katz S, Bally-Cuif L (2013) miR-9: a versatile regulator of neurogenesis. Front Cell Neurosci 7:220 Coolen M, Katz S, Bally-Cuif L (2013) miR-9: a versatile regulator of neurogenesis. Front Cell Neurosci 7:220
36.
go back to reference Chen P, Price C, Li Z, Li Y, Cao D, Wiley A, He C, Gurbuxani S, Kunjamma RB, Huang H et al (2013) miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. Proc Natl Acad Sci U S A 110:11511–11516PubMedCentralPubMedCrossRef Chen P, Price C, Li Z, Li Y, Cao D, Wiley A, He C, Gurbuxani S, Kunjamma RB, Huang H et al (2013) miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. Proc Natl Acad Sci U S A 110:11511–11516PubMedCentralPubMedCrossRef
37.
go back to reference Kutty RK, Samuel W, Jaworski C, Duncan T, Nagineni CN, Raghavachari N, Wiggert B, Redmond TM (2010) MicroRNA expression in human retinal pigment epithelial (ARPE-19) cells: increased expression of microRNA-9 by N-(4-hydroxyphenyl) retinamide. Mol Vis 16:1475–1486PubMedCentralPubMed Kutty RK, Samuel W, Jaworski C, Duncan T, Nagineni CN, Raghavachari N, Wiggert B, Redmond TM (2010) MicroRNA expression in human retinal pigment epithelial (ARPE-19) cells: increased expression of microRNA-9 by N-(4-hydroxyphenyl) retinamide. Mol Vis 16:1475–1486PubMedCentralPubMed
38.
go back to reference Howell JC, Chun E, Farrell AN, Hur EY, Caroti CM, Iuvone PM, Haque R (2013) Global microRNA expression profiling: curcumin (diferuloylmethane) alters oxidative stress-responsive microRNAs in human ARPE-19 cells. Mol Vis 19:544–560PubMedCentralPubMed Howell JC, Chun E, Farrell AN, Hur EY, Caroti CM, Iuvone PM, Haque R (2013) Global microRNA expression profiling: curcumin (diferuloylmethane) alters oxidative stress-responsive microRNAs in human ARPE-19 cells. Mol Vis 19:544–560PubMedCentralPubMed
39.
go back to reference Liu GD, Zhang H, Wang L, Han Q, Zhou SF, Liu P (2013) Molecular hydrogen regulates the expression of miR-9, miR-21 and miR-199 in LPS-activated retinal microglia cells. Int J Ophthalmol 6:280–285PubMedCentralPubMed Liu GD, Zhang H, Wang L, Han Q, Zhou SF, Liu P (2013) Molecular hydrogen regulates the expression of miR-9, miR-21 and miR-199 in LPS-activated retinal microglia cells. Int J Ophthalmol 6:280–285PubMedCentralPubMed
40.
go back to reference Uchida K (2003) 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42:318–343PubMedCrossRef Uchida K (2003) 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42:318–343PubMedCrossRef
41.
go back to reference Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, Chan WC, Ho MR, Lai CH, Kao HW, Fang WL et al (2011) Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics 6:1189–1197PubMedCentralPubMedCrossRef Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, Chan WC, Ho MR, Lai CH, Kao HW, Fang WL et al (2011) Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics 6:1189–1197PubMedCentralPubMedCrossRef
42.
go back to reference Dong Z, Noda K, Kanda A, Fukuhara J, Ando R, Murata M, Saito W, Hagiwara M, Ishida S (2013) Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization. Mol Vis 19:536–543PubMedCentralPubMed Dong Z, Noda K, Kanda A, Fukuhara J, Ando R, Murata M, Saito W, Hagiwara M, Ishida S (2013) Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization. Mol Vis 19:536–543PubMedCentralPubMed
43.
go back to reference Gammons MV, Dick AD, Harper SJ, Bates DO (2013) SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 54:5797–5806PubMedCrossRef Gammons MV, Dick AD, Harper SJ, Bates DO (2013) SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 54:5797–5806PubMedCrossRef
Metadata
Title
MiR-9 regulates the post-transcriptional level of VEGF165a by targeting SRPK-1 in ARPE-19 cells
Authors
Changshin Yoon
Daejin Kim
Seonghan Kim
Ga Bin Park
Dae Young Hur
Jae Wook Yang
Sae Gwang Park
Yeong Seok Kim
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 9/2014
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-014-2698-z

Other articles of this Issue 9/2014

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2014 Go to the issue